
A Thermo Fisher Scientific R&D leader warns that laboratories rushing to adopt AI and automation in genetic analysis without first stabilizing consumable quality and traceability are building on unstable foundations.
Automation amplifies inconsistency; AI can flag problems but cannot explain them without metadata linking reagent and consumable lots to each run.
The real innovation ahead depends on robust assay design, consistent reagents, and disciplined traceability—not just smarter software.
What happened
Augustė Užuotaitė, R&D Supervisor at Thermo Fisher Scientific's Genetic Sciences division, argues that labs adopting AI and automation for genetic analysis must first stabilize their foundational inputs—reagents, consumables, and assay design—rather than chase speed without ensuring consistency.
Why it matters
Automation amplifies both quality and problems; inconsistent consumables (plates, seals, master mixes, tips) can introduce subtle errors that AI systems may detect but not explain. Without traceability linking reagent lots and consumable lots to results, AI-driven quality monitoring cannot identify root causes, only symptoms. Labs risk building sophisticated workflows on unstable foundations, shifting time from pipetting to troubleshooting rather than accelerating work.
What to watch
The article emphasizes that labs should qualify every new consumable lot under real automated conditions (hold times, ambient exposure, mixing steps) before production release, and embed traceability into every run by linking reagent lots, consumable lots, staging conditions, and instrument IDs to results. This foundational work determines whether AI-enabled genetic analysis produces insight or scales uncertainty.
Ask the AI about this article →
The article presents a critical warning about the sequence of technological adoption in laboratory genetics: organizations are deploying AI and automation without first establishing the physical and informational foundations those systems depend on. Thermo Fisher's Užuotaitė argues that this reversal of priorities—speed and sophistication before stability—introduces a false economy: labs spend less time pipetting but more time troubleshooting failures that automation has magnified. The core tension is that automation is a force multiplier; it accelerates both quality and problems equally, and without consistent consumables and rigorous traceability, it scales small variability into batch-level failures that are difficult to trace.
Multiplex qPCR (which amplifies multiple genetic targets in a single reaction) makes this stability problem acute because it leaves almost no margin for uncontrolled variability. Slight differences in plate optics, seal performance, or master mix formulation can introduce noise that competes with the actual signal. The article identifies three blind spots in common procurement and quality-control assumptions: sterility is not the same as nuclease-free or DNA-free certification; passing controls does not guarantee an entire plate is unaffected (edge effects and low-input losses can distort target wells); and master mix lots are not interchangeable despite appearing similar. These distinctions matter because genetic analysis builds credibility on reproducibility—a foundation that cannot exist without knowing, in detail, what consumables and reagents were used in each run.
The article's final argument reframes the role of AI: it is not a substitute for foundational discipline but an amplifier of data quality when that foundation is solid. AI can link observed Ct drift to specific reagent lots, instrument conditions, or staging problems—but only if those links are recorded. Without traceability embedded into every run, AI systems become sophisticated interpreters of noise rather than engines of insight.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
BHP, the world's largest mining company by market capitalization, has deployed AI across its operations

Team Liquid announced a new five-year extension of its long-running collaboration with Dell Technologies' Alie…

A University of Mississippi study published in Journal of Interactive Advertising found that AI ads succeed wh…

Goldman Sachs Research says AI supply and demand won't balance until the first half of 2028

Lam Research broke ground yesterday on a new lab in Tualatin, Oregon

Visa, Mastercard, and Fiserv joined the Agentic Payments Alliance (APA), a 26-company coalition led by stablec…
